Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Makenita Resources doubles land for iron-magnetite project in Saskatchewan, eyeing iron, magnetite, and hydrogen potential.

Market News
14 May 2026
Newsfile Corp
View Source
Bullish
pluang ai news

Makenita Resources has expanded its Serpentinization Iron-Magnetite Project in Saskatchewan from 23,517 to 51,304 acres, bordering Max Power Corp's land. The project targets iron and magnetite, with potential for naturally occurring hydrogen production through stimulating magnetite formations. With just over 30 million shares outstanding, the company expects significant leverage from exploration success and plans active development through 2026. This expansion enhances Makenita's position in key mineral projects across Canada, including tungsten, rare earths, cobalt, silver, and diamonds.

More News

Pension officials criticize SpaceX's IPO structure as overly favorable to Elon Musk's control.

Pension officials criticize SpaceX's IPO structure as overly favorable to Elon Musk's control.

Top pension officials from New York and California have expressed concerns about SpaceX's upcoming IPO, criticizing its dual-class share structure that grants Elon Musk significant voting power and control. They warn that this 'most management-favora...

Market News
Bearish
20 minutes ago
Ipsen unveils corabotase, a novel neuroinhibitor, showing promising Phase II results for facial line treatment.

Ipsen unveils corabotase, a novel neuroinhibitor, showing promising Phase II results for facial line treatment.

Ipsen has introduced corabotase, the first molecule in a new class of recombinant neuroinhibitors, designed to treat moderate to severe upper facial lines such as glabellar lines. Phase II trial data presented at the SCALE Symposium showed corabotase...

Others
Bullish
1 hour ago
Ipsen presents corabotase, a novel neuro-inhibitor, showing promising phase II results for facial wrinkle treatment.

Ipsen presents corabotase, a novel neuro-inhibitor, showing promising phase II results for facial wrinkle treatment.

Ipsen has introduced corabotase, the first molecule in a new class of recombinant neuro-inhibitors, at the SCALE symposium. Phase II trial data show corabotase's safety and efficacy in treating moderate to severe facial wrinkles, including glabellar ...

Market News
Bullish
1 hour ago
Herbal Dispatch inks exclusive EU-GMP supply deal to boost Canadian cannabis exports to Europe.

Herbal Dispatch inks exclusive EU-GMP supply deal to boost Canadian cannabis exports to Europe.

Herbal Dispatch Inc., a Canadian cannabis e-commerce platform, has signed an exclusive strategic supply agreement with a Portugal-based EU-GMP licensed cannabis processor. This deal enables Herbal Dispatch to export Canadian cannabis products to Euro...

Market News
Bullish
4 hours ago
Sage appoints new Chief Product Officer and Chief Strategy Officer to boost AI innovation and growth.

Sage appoints new Chief Product Officer and Chief Strategy Officer to boost AI innovation and growth.

Sage has appointed Krish Vitaldevara as Chief Product Officer and Anand Swaminathan as Chief Strategy Officer, joining the Executive Leadership Team in May and June 2026. Krish will lead global product strategy focusing on AI-powered solutions for sm...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App